Omeros (OMER) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.13% |
| Dec 31, 2025 | 12.46% |
| Sep 30, 2025 | -3.94% |
| Jun 30, 2025 | 23.19% |
| Mar 31, 2025 | 14.75% |
| Dec 31, 2024 | 15.13% |
| Sep 30, 2024 | 27.98% |
| Jun 30, 2024 | 31.75% |
| Mar 31, 2024 | 34.00% |
| Dec 31, 2023 | 31.57% |
| Sep 30, 2023 | 45.50% |
| Jun 30, 2023 | 37.75% |
| Mar 31, 2023 | 44.46% |
| Dec 31, 2022 | 38.41% |
| Sep 30, 2022 | 29.52% |
| Jun 30, 2022 | 41.77% |
| Mar 31, 2022 | 44.60% |
| Dec 31, 2021 | 44.19% |
| Sep 30, 2021 | 11.15% |
| Jun 30, 2021 | 25.82% |
| Mar 31, 2021 | 35.02% |
| Dec 31, 2020 | 29.87% |
| Sep 30, 2020 | 40.54% |
| Jun 30, 2020 | 3.81% |
| Mar 31, 2020 | 9.55% |
| Dec 31, 2019 | 66.10% |
| Sep 30, 2019 | 29.26% |
| Jun 30, 2019 | 16.97% |
| Mar 31, 2019 | 12.55% |
| Dec 31, 2018 | 42.14% |
| Sep 30, 2018 | 44.47% |
| Jun 30, 2018 | 35.76% |
| Mar 31, 2018 | 38.15% |
| Dec 31, 2017 | 34.35% |
| Sep 30, 2017 | 30.82% |
| Jun 30, 2017 | 43.08% |
| Mar 31, 2017 | 22.60% |
| Dec 31, 2016 | 20.05% |
| Sep 30, 2016 | 15.77% |
| Jun 30, 2016 | 2.40% |
| Dec 31, 2015 | 1.40% |